Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
International Journal of Medicinal Chemistry|April 15, 2017
Biophysical Approaches Facilitate Computational Drug Discovery for ATP-Binding Cassette ProteinsSteven V Molinski, Zoltán Bozóky, Surtaj H Iram, et al.
Journal of Biomolecular Screening|September 20, 2015
Facilitating Structure-Function Studies of CFTR Modulator Sites with Efficiencies in Mutagenesis and Functional ScreeningSteven V Molinski, Saumel Ahmadi, Maurita Hung, et al.
Essays in Biochemistry|October 5, 2011
Mammalian multidrug-resistance proteins (MRPs)Andrew J Slot, Steven V Molinski, Susan P C Cole
Frontiers in Oncology|November 30, 2017
Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer TherapeuticsJ Javier Hernandez, Michael Pryszlak, Lindsay Smith, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 22, 2014
Genetic, cell biological, and clinical interrogation of the CFTR mutation c.3700 A>G (p.Ile1234Val) informs strategies for future medical interventionSteven V Molinski, Tanja Gonska, Ling Jun Huan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 24, 2017
The Antiretroviral Agent Nelfinavir Mesylate: A Potential Therapy for Systemic SclerosisCecilia G Sanchez, Steven V Molinski, Rafael Gongora, et al.
Biochemical and Biophysical Research Communications|December 24, 2016
Computational proteome-wide screening predicts neurotoxic drug-protein interactome for the investigational analgesic BIA 10-2474Steven V Molinski, Vijay M Shahani, Stephen S MacKinnon, et al.
Proteins|March 24, 2018
Comprehensive mapping of cystic fibrosis mutations to CFTR protein identifies mutation clusters and molecular docking predicts corrector binding siteSteven V Molinski, Vijay M Shahani, Adithya S Subramanian, et al.
NPJ Genomic Medicine|June 27, 2017
Phenotypic profiling of CFTR modulators in patient-derived respiratory epitheliaSaumel Ahmadi, Zoltan Bozoky, Michelle Di Paola, et al.
EMBO Molecular Medicine|July 2, 2017
Orkambi® and amplifier co-therapy improves function from a rare CFTR mutation in gene-edited cells and patient tissueSteven V Molinski, Saumel Ahmadi, Wan Ip, et al.
Pageof 1